The editorial departments of all journals that publish papers dealing with synthesized organic compounds re quire presenting the experimental data on the content of elements such as C, H, and N in the analyte molecules obtained using an elemental analyzer. It is considered that the difference between the theoretical and experimental values on the element percentages in the molecule should not exceed 0.3, 0.05, and 0.1% for C, H, and N, respec tively. However, until now, nobody paid attention to the fact that the specified errors of determination of the ele ment percentages can be met only for high purity com pounds (purity degree >99%).
However, it is obvious that not all organic compounds prepared by organic chemists are high purity chemicals, as it is often impossible to prepare such chemicals using the standard equipment of a synthetic laboratory. This means that published experimental data on the percentag es of elements in a molecule are not correct (i.e., not true) for many compounds. Perhaps, some of the data have not been found experimentally but have been determined by calculations for the corresponding compounds identi fied by NMR or mass spectrometry. Therefore, various databases containing properties of organic compounds that depend on the degree of compound purity can give faulty values.
Meanwhile, organic elemental analysis can be a versa tile method for determining the degree of purity of high purity organic compounds, 1-4 including pharmaceuticals. In its potential, this method is either superior or equiva lent to the generally accepted methods. Apart from high accuracy, advantages of this method are versatility, high speed, and the absence of necessity to use standard samples of the analyte.
Previously, we demonstrated the possibility of fast screening of samples of pharmaceutical agents for the content of the active component by using elemental analysis. 5 The extensive introduction of this method of analysis would increase the level of quality control of pharmaceutical products and would create conditions for solving the topical problem: disclosure of adulterated products.
